Relatively high prevalence of subclinical iron deficiency in Japanese children: evidence from a preoperative

Yamato Hanawa1,2, Yuji Baba3, Wataru Murasaki4,5

  • 1Department of Pediatrics, Jikei University Kashiwa Hospital, Chiba, Japan. kazuyama2496@gmail.com.

BMC Pediatrics
|June 2, 2026
PubMed

Insights

Subclinical iron deficiency (ID) is common in asymptomatic children, even without anemia. Early identification through dietary and clinical risk assessment is crucial for pediatric care.

Area of Science:

  • Pediatric Health
  • Nutritional Science
  • Micronutrient Deficiencies

Background:

  • Iron deficiency (ID) is a prevalent childhood micronutrient deficiency, critical during infancy and early childhood due to rapid brain development.
  • Iron is vital for myelination, neurotransmitter synthesis, and neuronal energy metabolism, with early-life ID potentially linked to later attention and executive function deficits.
  • The full extent and reversibility of early-life iron deficiency's impact on cognitive development remain under investigation.

Purpose of the Study:

  • To determine the prevalence of iron deficiency (ID) in asymptomatic pediatric patients undergoing elective surgery.
  • To identify characteristics of children with ID, including those without anemia.
  • To inform strategies for early identification of iron deficiency in pediatric populations.

Main Methods:

  • Retrospective review of pediatric patients (January 2021-June 2024) undergoing elective surgery.
  • Exclusion criteria included hematologic disorders, severe chronic disease, active inflammation, or elevated C-reactive protein (CRP).
  • ID defined by age-specific low serum ferritin and/or transferrin saturation (TSAT) <16%; anemia by WHO 2024 criteria.

Main Results:

  • Of 129 eligible patients (6 months-4 years), 20.2% had ID (26/129), with 23 cases of ID without anemia and 3 with iron deficiency anemia (IDA).
  • All identified cases of ID were asymptomatic.
  • The ID group exhibited lower hemoglobin, MCV, MCH, serum iron, and ferritin, alongside higher RDW-CV, platelet count, and UIBC compared to the non-ID group.

Conclusions:

  • Subclinical iron deficiency is prevalent in asymptomatic Japanese children undergoing elective surgery.
  • Clinically silent iron deficiency can exist even in seemingly healthy children.
  • Routine pediatric care should emphasize dietary and clinical risk assessment for early ID identification, rather than relying solely on surgery-based screening.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...